ASSOCIATION BETWEEN GUT BRAIN AXIS AND VARIOUS DISORDERS - A LITERATURE REVIEW. by Muthukumaran Jothilingam et al.
ISSN: 2320-5407                                                                                      Int. J. Adv. Res. 7(7), 654-663 
654 
 
Journal Homepage: -www.journalijar.com 
 
 
 
 
Article DOI:10.21474/IJAR01/ 9406 
DOI URL: http://dx.doi.org/10.21474/IJAR01/9406 
 
RESEARCH ARTICLE 
 
ASSOCIATION BETWEEN GUT BRAIN AXIS AND VARIOUS DISORDERS – A LITERATURE 
REVIEW. 
 
Muthukumaran Jothilingam
1
, K.Kotteeswaran
2
, M.Manikumar
2
, Jagatheesan Alagesan
3
 and 
S.Bakiyalakshmi
4
. 
1. Assistant Professor, Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical Sciences, 
Chennai, India.  
2. Associate professor, Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical Sciences, 
Chennai, India. 
3. Professor & Principal,  Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical 
Sciences, Chennai, India. 
4. Clinical Physiotherapist, Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical 
Sciences, Chennai, India. 
…………………………………………………………………………………………………….... 
Manuscript Info   Abstract 
…………………….   ……………………………………………………………… 
Manuscript History 
Received: 20 May 2019 
Final Accepted: 22 June 2019 
Published: July 2019 
 
Key words:- 
Microbiota ,  Gut Brain Axis, Autism, 
Parkinson’s Disease, Schizophrenia. 
 
 
 
 
 
 
 
Aim: The aim of this review is to identify and summarize the existing 
evidences on association between gut brain axis and various disorders. 
Method: Research studies will be obtained from various data bases 
through computer based search  in  Pubmed, google scholar, Embase, 
and Cochrane. Obtained studies will be short listed according to  
inclusion criteria and its results will be reviewed and presented.  
Result: A total of 20 studies were potentially identified by the authors. 
Studies published in English language were included in this review. 
Conclusion: The gut microbe has been identified as the main source of 
highest biological variability confined in an individual and also 
provides constant antigenic stimulation shaping up the physiological 
immune response. 
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Introduction:- 
The gut–brain axis is the biochemical signaling that takes place between the gastrointestinal tract and the central 
nervous system..
[1] 
 Broadly defined, the gut-brain axis includes the central nervous system, neuroendocrine and 
neuroimmune systems including the hypothalamic–pituitary–adrenal axis (HPA axis), sympathetic and 
parasympathetic arms of the autonomic nervous system including the enteric nervous system and the vagus nerve, 
and the gut microbiota.
[1][3]
The enteric nervous system  has been described as a "second brain".
[5]
 The enteric 
nervous system can operate autonomously.
[5]
 It normally communicates with the central nervous system (CNS) 
through the parasympathetic (e.g., via the vagus nerve) and sympathetic (e.g., via the prevertebral ganglia) nervous 
systems.
[5]
Gut microorganisms benefit the host by collecting the energy from the fermentation of undigested 
carbohydrates and the subsequent absorption of short-chain fatty acids (SCFAs), acetate, butyrate, and 
propionate.
[4][7]
 Intestinal bacteria also play a role in synthesizing vitamin B and vitamin K as well as metabolizing 
bile acids, sterols, and xenobiotics.
[7]
 The systemic importance of the SCFAs and other compounds they produce are 
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like hormones and the gut flora itself appears to function like an endocrine organ,
[7]
 and dysregulation of the gut 
flora has been correlated with a host of inflammatory and autoimmune conditions.
[4][8] 
 
Gut-brain integration: 
The gut–brain axis, a bidirectional neurohumoral communication system, is important for maintaining homeostasis 
and is regulated through the central and enteric nervous systems and the neural, endocrine, immune, and metabolic 
pathways, and especially including the hypothalamic–pituitary–adrenal axis (HPA axis).[1] That term has been 
expanded to include the role of the gut flora as part of the “microbiome-gut-brain axis”, a linkage of functions 
including the gut flora.
[1][3][2]
 The gut flora can produce a range of neuroactive molecules, such as acetylcholine, 
catecholamines, histamine, melatonin, and serotonin, which is essential for regulating peristalsis and sensation in the 
gut.
[6]
 Changes in the composition of the gut flora due to diet, drugs, or disease correlate with changes in levels of 
circulating cytokines, some of which can affect brain function.
[6]
 The gut flora also release molecules that can 
directly activate the vagus nerve which transmits information about the state of the intestines to the brain.
[6]
 
Likewise, chronic or acutely stressful situations activate the hypothalamic–pituitary–adrenal axis, causing changes 
in the gut flora and intestinal epithelium, and possibly having systemic effects.
[6]
 Additionally, the cholinergic anti-
inflammatory pathway, signaling through the vagus nerve, affects the gut epithelium and flora.
[6]
 Hunger and satiety 
are integrated in the brain, and the presence or absence of food in the gut and types of food present, also affect the 
composition and activity of gut flora.
[6] 
 
Anxiety and mood disorders: 
As of January 2016 work on the relationship between gut flora and anxiety disorders and mood disorders including 
depression was at an early stage, with insufficient evidence to draw conclusions about a causal role for gut flora 
changes in these conditions, nor for the efficacy of any probiotic treatment.
[9]
People with anxiety and mood 
disorders tend to have GI problems; small studies have been conducted to compare the gut flora of people with 
major depressive disorder and healthy people, but those studies have had contradictory results.
[9]
Much interest was 
generated in the potential role of gut flora in anxiety disorders, and more generally in the role of gut flora in the gut-
brain axis, by studies published in 2004 showing that germ-free mice have an exaggerated HPA axis response to 
stress caused by being restrained, which was reversed by colonizing their gut with a Bifidobacterium species.
[2] 
 
Schizophrenia: 
People with schizophrenia tend to also have GI problems,
[6]
 but as of 2015, no studies had been carried out to 
compare the gut flora of people with schizophrenia with healthy people.
[3]
 Research causing schizophrenia-like 
symptoms in mice by giving them phencyclidine (PCP) has found changes to the gut flora of the treated mice 
compared with untreated mice.
[3] 
 
Autism: 
Around 70% of people with autism also have GI problems, and autism is often diagnosed at the time that the gut 
flora becomes established, indicating that there may be a connection between autism and gut flora.
[10]
Some studies 
have found differences in the gut flora of children with autism compared with normal children – most notably 
elevations in the amount of Clostridium in the stools of children with autism compared with the stools of the 
children without
[11]
 – but these results have not been consistently replicated.[10]Many of the environmental factors 
thought to be relevant to the development of autism would also affect the gut flora, leaving open the question 
whether specific developments in the gut flora drive the development of autism or whether those developments 
happen concurrently.
[3][10]
 As of 2016, studies with probiotics had only been conducted with animals; studies of 
other dietary changes to treat autism have been inconclusive.
[9] 
 
Parkinson's disease: 
As of 2015 one study had been conducted comparing the gut flora of people with Parkinson's disease to healthy 
controls; in that study people with Parkinsons had lower levels of Prevotellaceae and people with Parkinsons who 
had higher levels of Enterobacteriaceae had more clinically severe symptoms; the authors of the study drew no 
conclusions about whether gut flora changes were driving the disease or vice versa.
[3]
 
 
Method:- 
The gut–brain axis, a bidirectional neurohumoral communication system, is important for maintaining homeostasis 
and is regulated through the central and enteric nervous systems and the neural, endocrine, immune, and metabolic 
pathways, and especially including the hypothalamic–pituitary–adrenal axis (HPA axis). The gut flora also release 
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molecules that can directly activate the vagus nerve which transmits information about the state of the intestines to 
the brain. Mood disorders, Schizophrenia, Autism, and Parkinson’s disease are the specific conditions which 
associates with gut-brain-axis. This review is to identify and summarize the existing evidences on association 
between gut brain axis and various disorders. Studies were identifies by using following database.Pubmed, 
Google scholar, Embase, Cochrane, Pedro and Medline  
 
Review of Literature 
S.NO AUTHOR TITLE YEAR METHODOLOGY CONCLUSION 
1. Caso. JR, Balanza 
Martinez. V, Palomo. 
T, Garcia Bueno. B 
The microbiota and 
gut brain axis: 
contributions to 
immunopathogenesi
s of schizophrenia 
2016 Considering the study on 
microbiome and several 
research shows the potential 
role of gut microbiota on 
various neurologic and 
psychiatric conditions. The 
aim is to study the possible 
effect of these organisms in 
immunopathogenesis of 
schizophrenia. 
It is to conclude that 
the following research 
needs to improve 
certain advancements 
in personalized 
medicine and the 
future research should 
include several 
microbiota and certain 
therapies in order to 
improve symptoms 
and to decrease 
immue dysfunction in 
patient with 
schizophrenia.
[12] 
2. Hu. X, Wang. T, Jin. 
F 
Alzheimer’s disease 
and gut microbiota 
2016 The host brain function and 
cognitive behavior can be 
modulated by gut microbiota 
via microbiota-gut brain axis. 
The alterations in host 
cognitive behaviour, gut 
microbiota and gut 
physiology will increasing or 
decreasing risks of AD. Gut 
microbiota disturbance can 
induce increased 
permeability of intestine and 
blood brain barrier and it will 
raise the incidence of 
neurodegeneration disorder. 
The onset of AD support the 
hygiene hypothesis. 
All the results suggest 
that AD is closely 
related to the 
imbalance of gut 
microbe and it may 
begin in the gut. The 
personalized diet or 
intervention will 
probably become a 
new treatment for 
AD.
[13] 
3. Maqsood. R, Stone. 
TW 
The gut brain axis, 
BDNF, NMDA and 
CNS disorders 
2016 This review mainly focuses 
on the influence of GI tract 
on BDNF and its relationship 
with receptors for (N-methyl-
D-aspartate) which is 
associated with the 
development of 
schizophrenia and other 
psychopathologies, as these 
are believed to be involved in 
synaptic plasticity and 
cognitive function. GI 
microbiota will contribute to 
the pathophysiology of 
BDNF induced NMDAR 
dysfunction which is relevant 
The changes in the gut 
microbiota by using 
probiotics, prebiotics 
or antimicrobial drugs 
has been found 
promising as a 
therapeutic measure to 
counteract 
behavioural deficits 
which is useful to 
supplement the 
actions of drugs in the 
treatment of CNS 
disorders.
[14] 
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to developing novel 
therapeutics for 
schizophrenia and other 
related disorder. The central 
BDNF levels are reduced 
during the absence of GI 
microbes and this inhibits the 
maintenance of NMDAR 
production. The disinhibition 
of glutametergic output will 
disrupts the central signal to 
noise ratio and leads to 
aberrant synaptic behaviour 
and cognitive deficits. The 
BDNF function in the CNS 
can be modulated by gut 
microbiota via changes in 
neurotransmitter function by 
affection modulatory 
mechanisms such as the 
Kyneurenine pathway, or by 
changes in actions of short 
chain fatty acids in brain. 
4. Cepeda. MS, Katz. 
EG and Blacketer. C 
Microbiome-Gut 
brain axis: 
Probiotics and their 
association with 
depression 
2016 A large population based 
cross sectional study was 
conducted by National health 
to assess the association of 
probiotics with depression. 
During interview days they 
consume any probiotic food 
or supplement and the 
subjects were classified as 
depressed if patient health 
questionare scores were 
greater than or equal to 10. 
Unadjusted analysis suggest 
the subjects those who 
consume probiotics had 
lower adds of depression and 
after adjustment the effect 
was attenuated. 
As a result there is a 
lower rate of 
depression in the 
national sample and it 
should not associated 
with the use of 
probiotics.
[15] 
5. Luna. RA, Savidge. 
TC, Williams. KC 
The Brain-Gut- 
Microbiome Axis: 
what role does it 
play in Autism 
spectrum disorder? 
2016 The interactions between the 
CNS, GI system and micro-
organisms that live in the GI 
tract can be called as brain-
gut-microbiome axis. FGIDs 
commonly occur in children 
with ASD and is closely 
associated with the signs of 
brain-gut-microbiome axis. 
The studies suggest 
that the gut 
microbiome changes 
associated with ASD 
and with GI disorders 
in children with ASD. 
The following studies 
should be treating 
ASD behaviours with 
novel therapies and 
new techniques for 
identifying GI 
disorders in children 
with ASD.
[16] 
6. Kennedy PJ, Cryan     
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JF, Dinan 
TG,  Clarke G 
 
Kynurenine pathway 
metabolism and the 
microbiota-gut-brain 
axis 
2016 Kynurenine pathway 
metabolism focuses mainly 
on structural and functional 
dynamics of gut microbiota  
and signaling pathway of 
brain gut axis. It is  regulated 
by microbial control of 
neuroendocrine function and 
components of immune 
system. 
As a  result, the gut 
microbiota represents 
a tractable target to 
modulate the 
kynurenine pathway 
metabolism.
[17]
  
7. Santocchi 
E, Guiducci 
L, Fulceri F, Billeci 
L, Buzzigoli 
E, Apicella 
F, Calderoni 
S, Grossi E, Morales 
MA, Muratori F 
 
Gut to brain 
interaction in 
Autism Spectrum 
Disorders: a 
randomized 
controlled trial on 
the role of probiotics 
on clinical, 
biochemical ad 
neurophysiological 
parameters 
2016 A group of 100 preschoolers 
with ASD can be classified 
into two  
groups and it will be 
randomized 1:1 to regular 
diet with probiotics or with 
placebo for six month. After 
six months from baseline in 
order to evaluate the possible 
changes in: (1) GI symptoms; 
(2) autism symptoms 
severity; (3) affective and 
behavioral comorbid 
symptoms; (4) plasmatic, 
urinary and fecal biomarkers 
related to abnormal intestinal 
function; (5) 
neurophysiological patterns. 
As results could add 
information to the 
relationship between 
phthalates levels, 
clinical features and 
neurophysiological 
patterns in ASD.
[18] 
 
8. Emge JR, Huynh 
K, Miller EN, Kaur 
M, Reardon 
C, Barrett 
KE, Gareau MG 
 
Modulation of the 
microbiota-gut-brain 
axis by probiotics in 
a murine model of 
inflammatory bowel 
disease 
2016 DSS (5 days) was 
administered via drinking 
water followed by 3 or 9 
days of normal drinking 
water to assess behavior 
during active or resolving 
inflammation, respectively. 
Disease (weight, colon 
length, and histology) was 
assessed and the composition 
of the gut microbiota was 
characterized by using qPCR 
on fecal pellet DNA. In a 
subset of mice, pretreatment 
with probiotics was started 1 
wk prior to commencing 
DSS. During active 
inflammation (8 days), mice 
demonstrated impaired 
recognition memory and 
exhibited anxiety-like 
behavior vs. 
As a resut, mood and 
behavior are present 
during acute 
inflammation in 
murine IBD and 
associated with 
dysbiosis and that 
these outcomes can be 
prevented by the 
administration of 
probiotics.
[19] 
 
9. Brzozowski 
B, Mazur-Bialy 
A, Pajdo R, Kwiecien 
S, Bilski 
J, Zwolinska-Wcislo 
M, Mach 
Mechanisms by 
which stress affects 
the experimental 
and clinical 
inflammatory bowel 
disease (IBD). Role 
2016 It is to provide an overview 
of experimental and clinical 
evidences that stress 
activates the brain-
gut axis which results in a 
mucosal mast cells activation 
It is to conclude that, 
an increased microbial 
load in the colonic 
tissue, excessive 
cytokine release and a 
partially blunted 
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T, Brzozowski T. 
 
of Brain-Gut axis and an increase in the 
production of 
proinflammatory cytokines 
and other endocrine and 
humoral mediators. 
immune reactivity in 
response to stress 
result in its negative 
impact on IBD.
[20] 
 
10. Li Q, Zhou JM 
 
The microbiota-gut-
brain axis and its 
potential therapeutic 
role in autism 
spectrum disorder 
2016  Gastrointestinal symptoms 
and compositional changes in 
the gut microbiota frequently 
accompany cerebral 
disorders in patients with 
ASD. A disturbance in 
the gut microbiota, which is 
usually induced by a 
bacterial infection or chronic 
antibiotic exposure, has been 
implicated as a potential 
contributor to ASD. 
As a result, the salient 
observations of the 
disruptions of the 
microbiota-gut-
brain axis in the 
pathogenesis of ASD 
and reveals its 
potential therapeutic 
role in autistic 
deficits.
[21] 
 
11. RM. Stilling, TG. 
Dinan, JF. Cryan 
Microbial genes, 
brain and behaviour 
– epigenetic 
regulation of the gut 
– brain axis 
2014 The microbial composition  
is associated with alterations 
in behaviour and cognition 
has significantly contributed 
to establishing the microbiota 
gut brain axis. A role for this 
axis in health and disease, 
ranging from stress related 
disorders such as depression, 
anxiety and irritable bowel 
syndrome to  
neurodevelopmental 
disorders such as autism. 
In conclusion, the 
fields of epigenetics 
and microbiology are 
converging at many 
levels and more 
interdisciplinary 
studies are necessary 
to unravel the full 
range of this 
interaction.
[22] 
12. John F. Cryan, 
Timothy G. Dianan 
Mind – altering 
micro – organisms: 
The impact of the 
gut  microbiota on 
brain and behaviour 
2012 The gut microbiota also 
communicates with the CNS 
possibly through neural, 
endocrine and immune 
pathways and thereby 
influences brain function and 
behaviour. Studies in germ 
free animals and in animals 
exposed to pathogenic 
bacterial infections, probiotic 
bacteria or antibiotic drugs 
suggest a role for the gut 
microbiota 
in the regulation of anxiety, 
mood, cognition and pain. 
It suggest that 
modulation of the gut 
microbiota may be a 
tractable strategy for 
developing novel 
therapeutics for 
complex CNS 
disorders.
[23] 
13. Paul Forsythe, 
Mobuyuki Sudo, 
Timothy Dinan, 
Valerie H Taylor, 
John Bienenstock 
 
Mood and gut 
feelings 
2010 The mass of intestinal 
bacteria represents a virtual 
inner organ with 100 times 
the total genetic material 
contained in all the cells in 
the human body. Commencal 
organisms live in a state of 
harmonious symbiosis with 
each other and their host, 
however, a disordered 
balance amongst gut 
As a result, this 
review focuses on 
these data and 
suggests that the 
concept should be 
explored further to 
increase our 
understanding of 
mood disorders, and 
possibly even uncover 
missing links to a 
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microbes is now thought to 
be an associated or even 
causal factor for chronic 
medical conditions as varied 
as obesity and inflammatory 
bowel diseases. While 
evidence is still limited in 
psychiatric illnesses, there 
are rapidly coalescing 
clusters of evidence which 
point to the possibility that 
variations in the composition 
of gut microbes may be 
associated with changes in 
the normal functioning of the 
nervous system. 
number of co-morbid 
diseases.
[24] 
14. Timothy G. Dinan, 
John F. Cryan 
Regulation of the 
stress response by 
the gut microbiota: 
Implications for 
psychoneuroendocri
nology 
2012 The animals treated with 
probiotics have a blunted 
HPA response. Stress 
induces increased 
permeability of the gut 
allowing bacteria and 
bacteria antigens to cross the 
epithelial barrier and activate 
a mucosal immune response, 
which in turn alters the 
composition of the 
microbiome and leads to 
enhanced HPA drive. 
 
The gut microbiota 
must be taken into 
account when 
considering the 
factors regulating with 
HPA.
[25] 
15. Jane A. Foster, Karen 
– Anne Mcvey 
Nessfeld 
Gut-brain axis: how 
the microbiome 
influences anxiety 
and depression 
2013 Studies  reveal the 
importance 
of gut microbiota to the 
function of the CNS. 
Bidirectional communication 
between the brain and the 
gut has long been 
recognized. 
Gut  microbiota are an 
important 
player in how the 
body influences the 
brain, contribute 
to normal healthy 
homeostasis, and 
influence risk of 
disease, 
including anxiety and 
mood disorders.
[26] 
16. Elaine Y Hsian, Sara 
W. McBride, Sophia 
Hsien 
Microbiota 
modulate 
behavioural and 
physiological 
abnormalities 
associated with 
neurodevelopmental 
disorders 
2013 A serious 
neurodevelopmental 
condition that is diagnosed 
based on the 
presence and severity of 
stereotypic behavior and 
deficits in language 
and social interaction. 
Adult offspring of 
immune- 
activated mothers 
exhibit increased gut 
permeability 
and abnormal 
intestinal cytokine 
profiles.
[27] 
17. Anderson G, Seo M, 
Berk M, Carvalho 
AF, Maes M 
Gut permeability 
and microbiota in 
parkinson’s disease: 
Role of depression, 
Tryptophan 
catabolities, 
Oxidative and 
2016 It integrate the wider 
biological changes in PD, 
including increased oxidative 
and nitrosative stress, 
immune inflammatory 
processessm tryptophan 
catabolities and alterations in 
As a result, by driving 
tryptophan down the 
kynurenine pathway 
pro inflammatory 
cytokines and chronic 
stress driven 
activation of the 
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Nitrosative stress 
and Melatonergic 
pathways 
serotoninergic and 
melatoninergic pathways. 
hipothlamic pituitary 
adrenal axis decrease 
the availability of 
serotonin as a 
precursor for 
activation of the 
melatonergic 
pathways.
[28] 
18. Kohler CA, Maes M, 
Slyepchenko A, Berk 
M, Solmi M, Lanctot 
KL, Carvalho AF 
The Gut-brain axis, 
including the 
microbiome, Leaky 
gut and bacterial 
translocation: 
Mechanisms and 
pathophysiological 
role in Alzheimer’s 
disease 
 
2016 The most prevalent 
hypothesis for AD is the 
amyloid hypothesis, which 
states that changes in the 
proteolytic processing of the 
amyloid precursor protein 
leads to the accumulation of 
the amyloid beta peptide. 
Amyloid beta then triggers 
an immune response that 
drives neuroinflammation 
and neurodegeneration in 
AD. The specific role of gut 
microbiota in modulating 
neuroimmune functions well 
beyond the gastrointestinal 
tract may constitute an 
important influence on the 
process of 
neurodegeneration. 
As a result, we 
summarize possible 
mechanisms that 
could mediate the 
involvement of gut 
brain axis in AD 
physiopathology, and 
propose an integrative 
model.
[29] 
19. Karakula-Juchnowicz 
H, Dzikowski M, 
Pelczarska A, 
Dzikowska I, 
Juchnowicz D 
The brain-gut axis 
dysfunctions and 
hypersensitivity to 
food antigens in the 
etiopathogenesis of 
schizophrenia 
 
2016 The factors which is involved 
in the functioning of brain 
gut axis and important for the 
development of 
schizophrenia, i.e, 1, 
intestinal microbiome, 2. 
Permeable intestine, 3. 
Hypersensitivity to food 
antigens, including gluten 
and casein of cow’s milk. It 
indicate the probiotics, and 
the implementation of 
antibiotic therapy of specific 
treatment groups. 
As a result, further 
research is needed on 
links between the 
intestinal microbiome 
and intestinal function 
as factors mediating 
the activation of the 
immune system and 
the development and 
further course of 
schizophrenia.
[30] 
20. GB Rogers, DJ 
Keating, RL Young, 
M-L Wong, J Licinio 
and S Wesselingh 
From gut dysiosis to 
altered brain 
function and mental 
illness: mechanisms 
and pathways 
2016 The potential of dysbiosis to 
contribute 
to psychopathology and the 
evidence linking disruption 
of gut 
microbiota with specific 
psychiatric disorders. We 
examine the 
role of the microbiome in 
neurological development 
and regulation, 
and consider its contribution 
to aging-related morbidity. 
As a result, the 
potential for 
modification of the 
gut microbiome to 
provide clinical 
benefit in the context 
of altered brain 
function.
[31] 
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Discussion:- 
This study shows various associated disorders of the gut brain axis. As of January 2016 work on the relationship 
between gut flora and anxiety disorders and mood disorders including depression was at an early stage, with 
insufficient evidence to draw conclusions about a causal role for gut flora changes in these conditions, nor for the 
efficacy of any probiotic treatment.
[9]
 Caso et all reported about the future research should include several 
microbiota and certain therapies in order to improve symptoms and to increase dysfunction in patient with 
schizophrenia.
[12]
 Hu X et all reported that the personalized diet or intervention will probably became a new 
treatment for AD.
[13] 
 Luna RA, et all reported that the following studies should be treating ASD behaviours with 
novel therapies and new techniques for identifying GI disorders in children with ASD.
[16 
 Cepeda MS, et all reported 
that the lower rate of depression in the national sample and it should not associated with the use of probiotics.
[15]
 
Maqsood R, et all reported that the changes in the gut microbiota by using probiotics, prebiotics or antimicrobial 
drugs has been found promising as a therapeutic measure to counteract behavioural deficits which is useful to 
supplement the actions of drugs in the treatment of CNS disorders.
[14] 
 Kennedy PJ, et all reported that the gut 
microbiota represents a tractable target to modulate the kynurenine pathway metabolism.
[17] 
Emge JR, et all reported 
that the  mood and behavior are present during acute inflammation in murine IBD and associated with dysbiosis and 
that these outcomes can be prevented by the administration of probiotics.
[19]
 Timothy G, et all reported that the gut 
microbiota must be taken into account when considering the factors regulating with HPA.
[25] 
 Elaine Y Hsian, et all 
reported that the adult offspring of immune-activated mothers exhibit increased gut permeability and abnormal 
intestinal cytokine profiles.
[27] 
 
Conclusion:- 
The reviewed article shows the various disorders of the gut brain axis. The gut microbe has been identified as the 
main source of highest biological variability confined in an individual and also provides constant antigenic 
stimulation shaping up the physiological immune response. Studies of microbiota gut brain axis could provide a 
deeper understanding of the relationship between the intestinal bacteria and their hosts which could help to suggest 
potential therapeutic strategies through affecting the composition of gut microbiota. 
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